Sign up for Free, Daily ATTR-CM News & Insights

Get the latest news, perspectives, and information about ATTR-CM sent directly to your inbox. Registration is FREE and only takes a minute.

Latest ATTR-CM News

• Benefits of gene-silencing therapies in ATTR-CM may depend on TTR stabilizer use
  September 16, 2026
• Clinical trial to examine if acoramidis can reverse heart changes in ATTR-CM
  September 2, 2026
• ATTR-CM looks different in women and men
  August 19, 2026
• SGLT2i use reduces hospitalizations and mortality in ATTR-CM
  August 12, 2026
• Eplontersen falls short in major ATTR-CM study
  August 5, 2026
• Acoramidis may support kidney health alongside heart benefits, study finds
  July 9, 2026
• New study calls for more inclusive patient data in rare disease research
  June 29, 2026
• Coramitug obtains Fast Track designation for ATTR-CM
  May 22, 2026
• TTR stabilizer therapy increases naturally occurring antibodies in ATTR-CM
  April 16, 2026
• Acoramidis shows sustained benefits in ATTR-CM at 54-month follow-up
  April 9, 2026

Exclusive ATTR-CM Features

• How to ‘Light Up for Rare’ on Rare Disease Day
  February 27, 2026
• Rare Patient Voice rewards patients and caregivers for sharing their insights
  February 6, 2026
• What’s the link between ATTR-CM and spinal stenosis?
  December 12, 2025
• What to expect during a heart biopsy to confirm ATTR-CM
  October 24, 2025
• When to seek a second opinion after an ATTR-CM diagnosis
  September 26, 2025
• How to keep track of your medical records for ATTR-CM
  August 8, 2025
• How to handle anxiety during the wait for ATTR-CM test results
  August 1, 2025
• Advice for dealing with a difficult ATTR-CM prognosis
  July 29, 2025
• What is an ATTR-CM mutation carrier?
  July 23, 2025
• What is Donegal Amy?
  July 16, 2025